Fizex Pharmaceuticals Private Limited
About Fizex Pharmaceuticals Private Limited
Data last updated:
Fizex Pharmaceuticals Private Limited was a private limited company based in Patna, Bihar, India. The company has been struck off by the Registrar of Companies, typically due to non-filing of annual returns or failure to commence business. It is no longer operational and cannot enter into any legal contracts or agreements. It operated in the diversified business activities segment of the business services sector. It was incorporated on 13 April 2016.
The company was registered with the Registrar of Companies (ROC), Patna, under CIN U74999BR2016PTC031383.
The company had an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It was led by directors Jyotsana and Anita Jha.
Its last annual general meeting (AGM) was held on 29 September 2018, and its latest financial statements are for the year ended 31 March 2018. The registered office was at Patna, Bihar.
As per the financials filed for FY 2018, the company reported a revenue of ₹62.62 Lakh, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹68,909 (net margin 1.1%) and EBITDA of ₹3.32 Lakh (EBITDA margin 5.3%).
Company details
Contact details
Fizex Pharmaceuticals Private Limited's registered office is in Patna, Bihar.
- Registered AddressC/O Dhirendra Kumar Singh No. – 151 Arpana Bank Colony Phase – 2 Bailey Road D, Anapur, Patna, Bihar, India – 801503
- IndustryBusiness Services, Miscellaneous Business Activities, Other Services
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Fizex Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Fizex Pharmaceuticals Private Limited, buy the company report.
Financials of Fizex Pharmaceuticals Private Limited
FY 2018 filings availableFizex Pharmaceuticals Private Limited reported revenue of ₹62.62 Lakh (up 232% YoY) for FY 2018.
Compounded Annual Growth Rate (CAGR)
Revenue rose 232% in the latest year. EBITDA rose 269% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2017-18 | FY 2016-17 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | ||
| Other Income | ||
| Total Revenue | ||
| Cost of Materials Consumed | ||
| Employee Benefit Expense | ||
| Finance Costs | ||
| Depreciation and Amortisation | ||
| Other Expenses | ||
| Total Expenses | ||
| EBITDA | ₹3.32 Lakh | |
| Profit Before Tax | ||
| Tax Expense | ||
| Net Profit (PAT) | ₹68,909 | |
| Balance Sheet | ||
| Share Capital | ||
| Reserves and Surplus | ||
| Net Worth (Total Equity) | ||
| Long-term Borrowings | ||
| Short-term Borrowings | ||
| Trade Payables | ||
| Total Liabilities | ||
| Fixed Assets | ||
| Investments | ||
| Inventories | ||
| Trade Receivables | ||
| Cash and Bank Balance | ||
| Total Assets | ||
Financial Ratios
| Metrics | FY 2017-18 | FY 2016-17 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | 5.3% | |
| Net Profit Margin | 1.1% | |
| Return on Equity (ROE) | ||
| Return on Capital Employed (ROCE) | ||
| Return on Assets (ROA) | ||
| Liquidity and Debt | ||
| Current Ratio | ||
| Quick Ratio | ||
| Debt-to-Equity Ratio | ||
| Interest Coverage Ratio | ||
| Efficiency and Growth | ||
| Asset Turnover | ||
| Receivable Days | ||
| Payable Days | ||
| Inventory Days | ||
| Revenue Growth | ||
| Net Profit Growth | ||
To see the full financial statements and ratios of Fizex Pharmaceuticals Private Limited, buy the company report.
Board of directors of Fizex Pharmaceuticals Private Limited
Fizex Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Jyotsana Also directs: Fizex Lifesciences Private Limited | Director | 13 Apr 2016 | 10 Years 6 Months | As last reported |
| Anita Jha Also directs: Fizex Healthcare Private Limited | Director | 13 Apr 2016 | 10 Years 6 Months | As last reported |
Peer comparison
Fizex Pharmaceuticals Private Limited is compared with the 6 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Acer Pharmaceuticals Private Limited | ₹62.91 Lakh (FY 2025) | 32.0% | Chennai, Tamil Nadu, India | |||
| Innings Pharmaceuticals Private Limited | ₹62.87 Lakh (FY 2025) | 9.0% | Delhi, India | |||
| Organcare Pharmaceuticals Private Limited | ₹62.81 Lakh (FY 2025) | 28.0% | Indore, Madhya Pradesh, India | |||
| Fizex Pharmaceuticals Private Limitedthis company | ₹62.62 Lakh (FY 2018) | ₹68,909 | 1.1% | 232.0% | Patna, Bihar, India | |
| Perron Pharmaceuticals Private Limited | ₹62.59 Lakh (FY 2025) | 13.0% | Delhi, India | |||
| Reetosh Pharmaceuticals Private Limited | ₹62.54 Lakh (FY 2025) | 16.0% | Ranchi, Jharkhand, India | |||
| Allegro Pharmaceuticals Private Limited | ₹62.32 Lakh (FY 2023) | 3.0% | Kozhikode, Kerala, India |
To see the full peer comparison of Fizex Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Fizex Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Fizex Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Fizex Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Fizex Pharmaceuticals Private Limited has 2 board changes on record since 2016: 2 appointments. The latest: Anita Jha was appointed as Director on 13 Apr 2016.
Frequently asked questions
Fizex Pharmaceuticals has a status of "Struck Off" as per MCA records. This means the company has been officially removed from the Register of Companies, typically due to non-filing of annual returns or failure to commence business within one year of incorporation. A struck-off company cannot enter into any legal contracts or agreements, and any dealings with such an entity carry significant legal and financial risk.
Fizex Pharmaceuticals was a private limited company based in Patna, Bihar, India. The company worked in miscellaneous business activities, within the business services industry. It was incorporated on 13 April 2016 and is registered under CIN U74999BR2016PTC031383. The company has been struck off by the Registrar of Companies and is no longer operational.
The CIN (Corporate Identification Number) of Fizex Pharmaceuticals is U74999BR2016PTC031383. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
The registered office of Fizex Pharmaceuticals is at CO Dhirendra Kumar Singh No. – 151 Arpana Bank Colony Phase – 2 Bailey Road D, Anapur, Patna, Bihar, India – 801503.
Fizex Pharmaceuticals was incorporated on 13 April 2016. It is registered with the Registrar of Companies, Patna.
The latest financial statements of Fizex Pharmaceuticals on record with the MCA are for the year ended 31 March 2018. Its last annual general meeting was held on 29 September 2018. Year-wise statements from FY 2017 are in the company report.
Fizex Pharmaceuticals operated in the business services industry, in the miscellaneous business activities segment. It worked in this industry before it was struck off.
The peers of Fizex Pharmaceuticals by revenue are Acer Pharmaceuticals Private Limited, Innings Pharmaceuticals Private Limited, Organcare Pharmaceuticals Private Limited, Perron Pharmaceuticals Private Limited, Reetosh Pharmaceuticals Private Limited and 1 more, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).
Anita Jha was appointed as Director on 13 Apr 2016. Jyotsana was appointed as Director on 13 Apr 2016.
The compliance status of Fizex Pharmaceuticals is compliant as of 25 August 2026.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
